Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer.
Alberola V, Sarries C, Rosell R, Taron M, de las Peñas R, Camps C, Massuti B, Insa A, Garcia-Gomez R, Isla D, Artal A, Muñoz MA, Cobo M, Bover I, Gonzalez-Larria JL, Terrasa J, Almenar D, Barcelo R, Diz P, Sanchez-Ronco M, Sanchez JJ.
Alberola V, et al. Among authors: taron m.
Clin Lung Cancer. 2004 May;5(6):360-5. doi: 10.3816/clc.2004.n.014.
Clin Lung Cancer. 2004.
PMID: 15217535
Clinical Trial.